L3VLUP
ProSign in

ALNY in the 13F filings

Alnylam Pharmaceuticals Inc · CUSIP 02043Q107

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 26 Jan 2024
Managers listing it
15
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 15 listed it in both
Shares listed
52,050,465
combined, among listed positions
Reported value
$10.0bn
combined, at the quarter end

Among the 93 comparable managers: 5 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ALNY in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

15 of 15 holders

ActionFiling
Capital World Investors16,174,563$3.1bn0.55%Trimmed-354,74513 Feb 2024 (the filing on sec.gov)
Fidelity (FMR LLC)10,312,356$2.0bn0.15%Trimmed-969,0505 Nov 2026 (the filing on sec.gov)
Wellington Management Group LLP7,214,198$1.4bn0.26%Added+782,38412 Feb 2024 (the filing on sec.gov)
Baillie Gifford & Co6,967,097$1.3bn1.06%Trimmed-1,196,04226 Jan 2024 (the filing on sec.gov)
Dodge & Cox3,674,310$703m0.45%Trimmed-72,84522 Feb 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc3,483,969$667m0.09%Trimmed-441,03516 Feb 2024 (the filing on sec.gov)
Capital Research Global Investors2,930,079$561m0.14%Added+146,23613 Feb 2024 (the filing on sec.gov)
AllianceBernstein LP520,839$100munder 0.1%Trimmed-19,86714 Feb 2024 (the filing on sec.gov)
Squarepoint Ops LLC335,826$64m0.12%Added+98,19214 Feb 2024 (the filing on sec.gov)
Janus Henderson Group Ltd278,081$53munder 0.1%Trimmed-15,40914 Feb 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP82,500$16m0.10%Added+36,60014 Feb 2024 (the filing on sec.gov)
Tudor Investment Corp64,096$12m0.10%Added+4,09214 Feb 2024 (the filing on sec.gov)
PDT Partners LLC5,916$1.1m0.13%Trimmed-8,55114 Feb 2024 (the filing on sec.gov)
Moore Capital Management LP4,635$887kunder 0.1%Trimmed-17,35014 Feb 2024 (the filing on sec.gov)
Farallon Capital Management LLC2,000$383kunder 0.1%Held014 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
18 in Q3 2024 to 21 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ALNY by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20134$407mn.a.n.a.
Q3 20136$1.2bnn.a.n.a.
Q4 20137$1.5bnn.a.n.a.
Q1 20148$1.6bnn.a.n.a.
Q2 20146$1.7bnn.a.n.a.
Q3 20147$2.1bnn.a.n.a.
Q4 20146$2.2bnn.a.n.a.
Q1 20158$2.9bnn.a.n.a.
Q2 20156$3.3bnn.a.n.a.
Q3 20155$2.1bnn.a.n.a.
Q4 20156$2.7bnn.a.n.a.
Q1 20168$2.0bnn.a.n.a.
Q2 20167$2.0bnn.a.n.a.
Q3 20168$2.6bnn.a.n.a.
Q4 20168$1.6bnn.a.n.a.
Q1 20179$2.2bnn.a.n.a.
Q2 201714$3.8bnn.a.n.a.
Q3 201715$5.7bnn.a.n.a.
Q4 201714$6.3bnn.a.n.a.
Q1 201815$5.7bnn.a.n.a.
Q2 201815$4.4bnn.a.n.a.
Q3 201814$3.9bnn.a.n.a.
Q4 201810$3.3bnn.a.n.a.
Q1 201911$4.6bnn.a.n.a.
Q2 201916$3.8bnn.a.n.a.
Q3 201911$4.4bnn.a.n.a.
Q4 201913$6.2bnn.a.n.a.
Q1 202012$5.7bnn.a.n.a.
Q2 202015$7.7bnn.a.n.a.
Q3 202013$7.6bnn.a.n.a.
Q4 202013$6.5bnn.a.n.a.
Q1 202114$7.2bnn.a.n.a.
Q2 202113$8.8bnn.a.n.a.
Q3 202114$9.7bnn.a.n.a.
Q4 202112$8.8bnn.a.n.a.
Q1 202212$8.9bnn.a.n.a.
Q2 202213$8.1bnn.a.n.a.
Q3 202217$10.8bnn.a.n.a.
Q4 202216$13.7bnn.a.n.a.
Q1 202319$11.5bnn.a.n.a.
Q2 202316$10.6bnn.a.n.a.
Q3 202317$9.7bnn.a.n.a.
Q4 202315$10.0bn59
Q1 202415$7.3bn106
Q2 202419$12.5bn128
Q3 202418$15.1bn711
Q4 202415$12.8bn87
Q1 202518$14.9bn117
Q2 202522$18.3bn1310
Q3 202533$26.6bn258
Q4 202524$23.4bn1528
Q1 202622$17.9bn1618
Q2 202621$15.9bn1718

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ALNY and LLY →ALNY and JNJ →ALNY and VRTX →Choose a stock to compare with ALNY →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ALNY, latest filings →Back to the 13F Explorer →